Introduction
Routine ultrasound screening in the second trimester has been part of the maternal healthcare program in Sweden and many western countries since the 1980s. In Sweden every pregnant woman is offered a routine ultrasound examination early in the second trimester, which is performed by specially trained midwives or doctors (1) .
Initially, the main reasons for routine ultrasound examination were assessing gestational age, evaluating the number of viable fetuses and checking the placenta. Currently, screening for fetal malformations using a checklist
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Routine ultrasound examination in the second trimester detects half of the major structural malformations in chromosomally normal fetuses. Chromosomal abnormalities have the highest probability for prenatal detection, and the majority are diagnosed by amniocentesis before the routine ultrasound examination.
has become an important part of the examination at the majority of obstetrical departments in Sweden (1) .
Prenatal detection of fetal abnormalities ranges from 17 to 85% (2, 3) . Large differences in study settings have a crucial impact on sensitivity. Many studies are published from tertiary centers (4) (5) (6) (7) (8) , which may yield different detection rates than smaller hospitals in terms of the prevalence, competence, and resources to detect malformations. The Helsinki Ultrasound Trial showed significant differences in prenatal detection rates of major malformations at a university hospital compared with a city hospital (9) , but other studies have shown that individual hospitals can achieve detection rates comparable to those of tertiary centers (10, 11) . Many of these studies were published or are based on data collected more than 10 years ago (2) (3) (4) (5) (8) (9) (10) (12) (13) (14) . In addition to knowledge in the field, the technical equipment and possibilities for detecting chromosomal abnormalities have improved over the years, so subsequent studies may show higher detection rates.
The aim of this study was to assess the sensitivity of the prenatal detection of chromosomal abnormalities and structural malformations in a routine clinical setting at € Ostersund County Hospital between 2006 and 2013.
Material and methods
This study was conducted between January 2006 and December 2013 in € Ostersund and included all babies who were delivered at € Ostersund County Hospital, Sweden and babies who were delivered at other hospitals as a consequence of a prenatal diagnosis of fetal abnormalities detected in € Ostersund. Fetuses lost by miscarriage, termination of pregnancy, or intrauterine fetal death with fetal abnormalities who were diagnosed by ultrasound in € Ostersund were also included. All fetuses included in the study underwent an ultrasound examination at the hospital before 22 weeks of gestation. The study population comprised 10 414 fetuses and newborns. This study was approved by the Regional Ethical Review Board of Ume a, Sweden (Dnr. 2014-139-31M).
€ Ostersund County Hospital is the only hospital with an ultrasound unit and delivery department in the county of J€ amtland-H€ arjedalen, and offers routine ultrasound examinations at 18 weeks of gestation to all pregnant women in the area as part of the official maternal healthcare program. Approximately 98% of the women residing in the area subsequently give birth at the hospital.
The routine ultrasound examinations were performed by specially trained midwives or, less frequently, obstetricians. Six specially trained midwifes and three obstetricians with competence in fetal ultrasound examinations were on duty during the study period, and their experience ranged from 1 month to 17 years. All examinations were performed transabdominally. The ultrasound scanners used were Antares and Acuson X 300 (Siemens Acuson Inc., Mountain View, CA, USA) with 3.5-5 MHz multifrequency curvilinear transducers. The allocated time for the examination was 30 min. Gestational age was calculated from the fetal biparietal diameter and femur length (15) . The examination included screening for fetal malformations using a checklist. The following structures were examined: fetal skull and brain (shape, midline echo, cavum septi pellucidi, ventricles, cerebellum, cisterna magna), neck, spine (three planes), profile, face, thorax, diaphragm, heart (four-chamber view; inflow/outflow tracts were assessed in 2010-2013), stomach, umbilical cord insertion and abdominal wall, kidneys, bladder, arms, legs, hands, feet, and skeleton. Gender was not routinely examined in singleton pregnancies. Additional ultrasound examinations were only performed based on medical indications.
When an abnormality was suspected during the routine scan, the woman was referred to an obstetrician with competence in fetal ultrasound examination at the Department of Obstetrics and Gynecology at € Ostersund County Hospital for further examination. When a second opinion or substantial investigation was needed, the woman was referred to a center with the appropriate capacities, most often the National Center for Fetal Medicine, St Olav's Hospital, Trondheim, Norway. If the suspected abnormality was not confirmed by either the obstetricians in € Ostersund or the referral center, the fetus was considered to have normal anatomy at the routine ultrasound examination.
In addition to the routine ultrasound examination in the second trimester, all women ≥35 years of age at the time of delivery, women with risk factors other than advanced maternal age, and women with ultrasound examinations indicating chromosomal abnormalities were offered chromosomal analyses after 15 completed gestational weeks at the earliest. From 2006 until October 2009, all women ≥35 years old were primarily offered amniocenteses. Starting October 2009, these women were initially offered first-trimester ultrasound examination screening for trisomies 21, 18, and 13 with a combination of fetal nuchal translucency thickness, serum free b-human chorionic gonadotropin, and pregnancy-associated plasma protein A measurements at 11-13 weeks of gestation, to evaluate the probability of chromosomal abnormality. Only if the probability was increased (>1/200) were they offered further chromosomal analyses.
After birth, all newborns were routinely examined by pediatricians and were followed up regarding congenital abnormalities until they were discharged from postnatal care or until a final diagnosis had been made.
Information on all babies receiving diagnoses of congenital abnormalities at the postpartum and neonatal wards was continuously forwarded to the ultrasound unit. Data about all prenatal and postnatal diagnoses of abnormalities were stored prospectively at the ultrasound unit. These data were compared with the diagnoses of congenital abnormalities stated before discharge from postnatal care in the computerized hospital databases according to the International Classification of Diseases 10th revision. In case of miscarriage, termination of pregnancy, or intrauterine fetal death with fetal abnormalities diagnosed before this event, results were retrieved from pathological anatomical examinations and chromosomal analyses.
All fetuses and babies were assigned only one diagnosis of abnormality even when they presented with multiple abnormalities, as long as it was not part of a multiple malformations sequence or syndrome. In cases with multiple abnormalities, the fetus/baby was assigned a main diagnosis of the abnormality considered by the authors to be the most clinically significant. Chromosomal abnormalities were always considered superior to structural malformations in fetuses/babies with abnormal chromosomes, except for balanced chromosomal abnormalities, which were considered chromosomally normal. Minor structural malformations not considered in the study were hemangioma and non-neoplastic nevus, preauricular appendage, hip instability and luxation, persistent ductus arteriosus, hydronephrosis <5 mm, persistent foramen ovale that regressed spontaneously, retention testis, inguinal hernia, syndactyly, and polydactyly.
An abnormality was considered to have been detected by ultrasound at the time in pregnancy when the abnormality was first suspected if the ultrasound diagnosis was in reasonable agreement with the definitive diagnosis, even if the final diagnosis was not made until later. A chromosomal abnormality was considered to have been diagnosed only after fluorescence in situ hybridization and/or fetal karyotyping had been performed and confirmed the abnormal chromosomes. All prenatally suspected abnormalities that could not be confirmed after birth, miscarriage, or termination of pregnancy were considered false-positive results, even in cases when the abnormality regressed during pregnancy, such as hydronephrosis or pleural effusion.
The structural malformations in chromosomally normal fetuses and babies were grouped according to organ system and to their clinical significance as minor or major. The distinction between minor and major was made in collaboration with a pediatrician with guidance from a proposal by the Royal College of Obstetrics and Gynaecology in 1997 (16) . The distinction was made between prenatal detection before and after gestational week 22 +0 , when, according to current Swedish law (17) , fetuses become babies.
The prevalence, sensitivity, specificity, positive and negative predictive values, and false-positive rate regarding chromosomal abnormalities and structural malformations were calculated. The calculations were performed per fetus, not per abnormality. Prevalence was defined as the number of fetuses and babies with confirmed diagnoses of abnormalities divided by the total number of fetuses included. The prenatal sensitivity was defined as the number of fetal abnormalities detected before delivery and confirmed after birth divided by the total number of confirmed abnormal fetuses. To calculate the sensitivity for the detection of fetal abnormalities by the routine ultrasound examination, we used the number of confirmed abnormalities detected before 22 weeks of gestation, except abnormalities detected by first-trimester ultrasound examination, divided by the total number of confirmed abnormal fetuses. A false-positive rate was defined as the number of fetuses receiving prenatal diagnoses of abnormalities that could not be confirmed after birth divided by the total number of fetuses receiving prenatal diagnoses of abnormalities. Statistical analyses were performed with MICROSOFT EXCEL PROFESSIONAL PLUS 2010 (Microsoft Corp. Redmond, WA, USA).
Results
During the study period, 10 344 babies were born at € Ostersund County Hospital, and 13 babies were born at other hospitals because of abnormalities detected during pregnancy by ultrasound examinations performed in € Ostersund. Also included in the study were 53 fetuses with abnormalities diagnosed in € Ostersund although these pregnancies were later terminated. Three fetuses were lost by miscarriage but were diagnosed with increased nuchal translucency thickness before the miscarriage, and the scheduled amniocentesis could not be undertaken. Those three fetuses received diagnoses of abnormalities postmortem. Additionally, one fetus also included in the study had a normal routine ultrasound scan but died in utero and was diagnosed with a chromosomal abnormality post-mortem. A total of 10 414 fetuses constituted the study population. Figure 1 shows the outcome of the study population. The mean age of the women at delivery was 30.5 years (range 15-52 years).
There were 243 fetuses and babies with confirmed abnormalities, prevalence 2.3% (243/10 414). Of these fetuses and babies, 23% (56/243) had chromosomal abnormalities, prevalence 0.5% (56/10 414), and 77% (187/243) had normal chromosomes with structural malformations, prevalence 1.8% (187/10 414).
One hundred and seven confirmed abnormalities were detected prenatally, yielding a total sensitivity for prenatal detection of fetal abnormalities of 44.0% (107/243; 95% ª 2016 Nordic Federation of Societies of Obstetrics and Gynecology, Acta Obstetricia et Gynecologica Scandinavica 96 (2017) 176-182 CI 37.8-50.2), a specificity of 99.9%, a positive predictive value of 94.7% and a negative predictive value of 98.7%. The great majority, 98 abnormalities, were detected before gestational week 22, yielding a total detection rate before 22 weeks of gestation of 40.3% (98/243; 95% CI 34.1-46.5). Of these diagnoses, 24 abnormalities (23 chromosomal abnormalities and one fetus registered as cystic hygroma but with stigmata of chromosomal abnormality by autopsy) were detected by amniocentesis primarily or after the first-trimester ultrasound screening for trisomies, before the routine ultrasound examination in the second trimester. The remaining 74 abnormalities (11 chromosomal abnormalities and 63 structural malformations) were detected by the routine ultrasound examination, yielding a sensitivity for prenatal detection by routine ultrasound examination alone of 30.5% (74/243). Nine confirmed structural malformations were detected prenatally but after gestation week 22.
In addition to these 107 prenatally detected fetuses, another six fetuses received prenatal diagnoses of fetal abnormalities that could not be confirmed after birth and were defined as false positives, yielding a false-positive rate of 5.3% (6/113). The false positives comprised two fetuses with hydronephrosis and two fetuses with pleural effusion that all regressed during pregnancy, as well as one fetus with suspected situs inversus and one fetus with suspected omphalocele who were both born healthy.
Of the prenatally detected true abnormalities, 68% (73/ 107) were structural malformations in chromosomally normal fetuses, and 32% (34/107) were chromosomal abnormalities. In fetuses and infants with structural malformations, 44% (82/187) were classified as major, prevalence 0.8% (82/10 414). The remaining 56% (105/187) were classified as minor, prevalence 1.0% (105/10 414). The sensitivity for prenatal detection before 22 weeks of gestation and the total prenatal detection rate for chromosomal abnormalities and major and minor structural malformations are shown in Table 1 . Depending on the organ system, the sensitivity for prenatal detection varied greatly. The highest detection rates were obtained for pulmonary malformations (83%, 5/6) and central nervous system malformations (82%, 9/11); the lowest rate was for cardiac malformations (13%, 6/46). Further information regarding detection rates of structural malformations according to organ system are given in Table 2 . For detailed information regarding the classification and detection rates for each category see Supplementary material (Table S1) .
Overall, 50% (53/107) of the prenatally detected abnormalities resulted in termination of pregnancy. In fetuses with chromosomal abnormalities that were detected prenatally, 88% (30/34) of the pregnancies were terminated; an additional two fetuses were lost by miscarriage, and one died in utero. In chromosomally normal fetuses with structural malformations that were detected prenatally, 32% (23/73) of the pregnancies were terminated, and an additional fetus was lost by miscarriage. Upon maternal request, before further test results were acquired, one minor structural malformation led to termination of pregnancy within the legal gestation age for termination of pregnancy according to Swedish law.
Discussion
In this study, we had a detection rate of fetal abnormalities of 40%, when detected before 22 completed weeks of gestation, and an additional 4%, when detected between 22 weeks and birth. Large differences in study settings with subsequent large differences in prenatal detection rates, ranging from 17 to 85% (2,3), occasionally make general comparison of detection rates between studies difficult. Factors such as the skills of the operator performing the examination, gestational age at the time of examination, numbers of routine examinations offered, technical equipment used, the postnatal follow up and the selection and definition of malformations included all have a crucial impact on the reported prevalence and prenatal detection rates.
The official maternal healthcare program described in this study is comparable to the majority of official maternal healthcare programs throughout Sweden today, and more than 97% of pregnant women in Sweden take the opportunity to have a routine ultrasound examination carried out (18) . In 2012, 16 of 21 counties in Sweden routinely offered a first-trimester examination with measurement of nuchal translucency thickness by ultrasound imaging combined with measurement of serum free b-human chorionic gonadotropin and pregnancy-associated plasma protein-A either to all women or to women comprising a high-risk group due to advanced maternal age (19) .
A strength of this study is the non-selected population of pregnant women from a well-defined area where approximately 98% of the women subsequently give birth at the hospital. € Ostersund County Hospital is the only facility in the area with an ultrasound unit and delivery Table 1 . Detection rate of chromosomal abnormalities and structural malformations in 243 abnormal fetuses and babies.
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Total prenatal Postnatal Chromosomal abnormalities  56  61  34  61  34  39  22  Structural malformations  Total  187  34  64  39  73  61  114  Major  82  50  41  55  45  45  37  Minor  105  22  23  27  28  73  77  Total  243  40  98  44  107  56 136 (19) . A weakness of this study is that it is retrospective. In our study, the prenatal detection rate for major structural malformations was twice as high as for minor structural malformations, at 55 and 27%, respectively. The great majority of major structural malformations detected prenatally were detected at the routine ultrasound examination. Finding a major structural malformation is of greater clinical interest to give parents-to-be the opportunity to decide whether to continue the pregnancy and to prepare for the best care for the baby. Another Swedish study published in 2006 by Saltvedt et al., with similar study settings and classification of major malformations, reported a detection rate for major structural malformations of 47% (12) .
Another reason to separate detection rates of major and minor structural malformations is that a high prevalence of minor malformations of less clinical importance can substantially affect the overall detection rate. In this study, atrial septum defect (n = 8), ventricular septum defect (n = 19) and hypospadias (n = 24) together account for a large number of minor structural malformations that were not detected prenatally. To prenatally differentiate an open foramen ovale in a normally formed fetus from a true pathological atrial septum defect or to detect a ventricular septum defect is very difficult, and hypospadias are very unlikely to be detected because gender was not routinely examined in singleton pregnancies in our study. Some studies do not include one or several of these malformations, which may yield a higher prenatal detection rate (3) (4) (5) 8, 13) . In other studies, the numbers of these malformations are not declared, or it is not possible to determine whether they are included (11, 14) . The reported prevalence of these malformations was also considerably higher in our study than in many other studies (3, 7, 8, 10, 20) . With exclusion of these malformations the total sensitivity for prenatal detection of fetal abnormalities increases from 44 to 56% in this study.
In accordance with many studies, we demonstrated high detection rates for structural malformations in the pulmonary system and the central nervous system (3, 4, (6) (7) (8) 10, 11, 13, 20) and low rates in the cardiac system (3, 4, 8, 10, 11) . The detection rates in the pulmonary system are often affected by the low numbers of malformations in this organ system. The low detection rate for malformations in the cardiac system in our study can partly be explained by the fact that chromosomal abnormalities were considered superior to structural malformations. Many fetuses with chromosomal abnormalities had cardiac malformations but were only registered according to their chromosomal abnormality. The way in which fetuses with abnormal chromosomes are registered or included at all differs among studies. Large differences in prenatal detection rates could also be observed within the same organ system. In the gastrointestinal system, the prenatal detection rate for malformations affecting the abdominal wall was 100% (7/7) but only 9% (1/11) for fetuses with any type of atresia.
Fetuses with chromosomal abnormalities had a higher probability of prenatal detection than chromosomally normal fetuses with structural malformations, at 61% and 39%, respectively. The majority of chromosomal abnormalities that were found prenatally were diagnosed before the routine ultrasound examination by amniocentesis in high-risk women. Two other Swedish studies with similar study settings also show higher prenatal detection rates for chromosomal abnormalities than for structural malformations in chromosomally normal fetuses (6, 11) . Romosan et al. (6) show almost identical total prenatal detection rates of 62% for chromosomal abnormalities and 40% for structural malformations in chromosomally normal fetuses at a university hospital. Notably, in their study, all women were routinely offered two ultrasound examinations in the second and third trimesters, and 13% of the chromosomal abnormalities were detected after 22 completed gestational weeks. An Italian study (7) also reports prenatal detection rates for chromosomal abnormalities of 61%, but in this study, all women were offered three ultrasound examinations during pregnancy. A Norwegian study from a general hospital (10) reports a prenatal detection rate for chromosomal abnormalities as low as 26%, but this study is based on data collected between 1989 and 1999, and both the technical equipment used and the possibilities of early fetal diagnosis for detection of chromosomal abnormalities differ from those in this study.
Conclusions
In a routine clinical setting at a county hospital with a non-selected population, half of the major structural malformations in chromosomally normal fetuses are detected by routine ultrasound examination. Improvement in detection of cardiac malformations is needed. Chromosomal abnormalities have a higher probability for prenatal detection than structural malformations in chromosomally normal fetuses. Today, many chromosomal abnormalities found prenatally are diagnosed by amniocentesis before routine ultrasound examination in the second trimester in high-risk women.
